🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Browsing Tag

J.P. Morgan

59 posts
Infographic highlighting Guidewire’s agreement to acquire hyperexponential for $1.7 billion in cash plus up to $400 million tied to recurring revenue targets, alongside AI-assisted insurance underwriting opportunities and financing and integration challenges.
Read More

Guidewire (GWRE) to acquire hyperexponential for up to $2.1bn as AI underwriting strategy accelerates

Guidewire has agreed to acquire London-based hyperexponential for $1.7 billion in cash plus up to $400 million tied to recurring revenue targets. The insurance software group expects the transaction to accelerate annual recurring revenue growth and deepen its position in AI-assisted commercial underwriting, while introducing substantial financing and integration requirements.
Read More

Wella’s IPO looks like a beauty growth story until the $2.29bn balance-sheet number enters the picture

Wella Company has filed for a New York Stock Exchange IPO after returning to profit and lifting adjusted EBITDA above $520 million. The owner of Wella Professionals, OPI, Clairol and ghd has delivered 22 consecutive quarters of constant-currency growth, but $2.29 billion of debt means the eventual valuation will depend as much on deleveraging as brand strength.
Read More

Bamboo Insurance has $879m of managed premium, but its IPO comes with a $548m debt question

CVC-backed Bamboo Insurance Services has filed for a New York Stock Exchange listing after managed premium approached $879 million and first-half revenue grew 40%. The capital-light insurance model is producing strong adjusted margins, but a $548 million term loan, declining GAAP profit and catastrophe exposure will make the eventual IPO price critical.